These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29695580)

  • 1. Clinical Implications of Transbronchial Biopsy for Surgically-resected Non-small Cell Lung Cancer.
    Yasukawa M; Sawabata N; Kawaguchi T; Kawai N; Taniguchi S
    In Vivo; 2018; 32(3):691-698. PubMed ID: 29695580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Preoperative Transbronchial Lung Biopsy for Non-small Cell Lung Cancer Less than 3-cm.
    Yasukawa M; Kawaguchi T; Kimura M; Tojo T; Taniguchi S
    In Vivo; 2021; 35(2):1027-1031. PubMed ID: 33622898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative biopsy does not affect postoperative outcomes of resectable non-small cell lung cancer.
    Taniguchi Y; Fukumoto K; Matsui H; Saito T; Murakawa T
    Gen Thorac Cardiovasc Surg; 2019 Jul; 67(7):615-623. PubMed ID: 30659509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Sekihara K; Hishida T; Yoshida J; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Matsuzawa R; Aokage K; Goto K; Tsuboi M
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):522-528. PubMed ID: 28482033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery.
    Gagliasso M; Migliaretti G; Ardissone F
    Lung Cancer; 2017 Sep; 111():124-130. PubMed ID: 28838382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
    Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
    Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.
    Lee JY; Choi JY; Heo JH; Han J; Jang SJ; Kim K; Kim J; Shim YM; Kim BT
    Nuklearmedizin; 2016; 55(1):7-14. PubMed ID: 26875430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
    Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
    Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer.
    Kohutek ZA; Wu AJ; Zhang Z; Foster A; Din SU; Yorke ED; Downey R; Rosenzweig KE; Weber WA; Rimner A
    Lung Cancer; 2015 Aug; 89(2):115-20. PubMed ID: 26078260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of recurrence and survival of c-Ia NSCLC diagnosed by transpleural methods.
    Voltolini L; Rapicetta C; Luzzi L; Scolletta S; Ligabue T; Campione A; Ghiribelli C; Gotti G
    J Cardiovasc Surg (Torino); 2008 Oct; 49(5):697-702. PubMed ID: 18670391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
    Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
    AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operable non-small cell lung cancer diagnosed by transpleural techniques : do they affect relapse and prognosis?
    Sawabata N; Maeda H; Ohta M; Hayakawa M
    Chest; 2001 Nov; 120(5):1595-8. PubMed ID: 11713140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: Comparative study of normal lung, emphysema, and pulmonary fibrosis.
    Miura K; Hamanaka K; Koizumi T; Kitaguchi Y; Terada Y; Nakamura D; Kumeda H; Agatsuma H; Hyogotani A; Kawakami S; Yoshizawa A; Asaka S; Ito KI
    Lung Cancer; 2017 Sep; 111():88-95. PubMed ID: 28838406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
    Gao L; Zhang H; Zhang B; Zhang L; Wang C
    Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.
    Kim SH; Lee HW; Go SI; Lee SI; Lee GW
    Oncotarget; 2016 Jun; 7(24):36198-36206. PubMed ID: 27105529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
    Kim K; Kim SJ; Kim IJ; Kim YS; Pak K; Kim H
    Nucl Med Commun; 2012 Jun; 33(6):613-20. PubMed ID: 22407127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.